A phase 3, randomized, active-controlled study to assess the safety and tolerability of meningococcal serogroup B vaccine bivalent rLP2086 in healthy adolescents and young adults

Autor: Ostergaard, Lars, Lucksinger, Gregg H., Absalon, Judith, Beeslaar, Johannes, Eiden, Joseph, Jansen, Kathrin U., York, Laura J., Quinn, Angela, Graversen, Mette E., Perez, John L.
Zdroj: In Vaccine 14 March 2016 34(12):1465-1471
Databáze: ScienceDirect